Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Hvidovre, Denmark). What requirements should a biomarker meet to be used in the clinical and epidemiological setting?. Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies

Member's Comments

No comment yet.

Related content which might interest you: Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 A new model for clinical trials to address the COVID-19 emergency Source: Breathe, 16 (2) 200220; 10.1183/20734735.0220-2020 Year: 2020 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 What kind of emphasis do we need in clinical research to enable personalised respiratory medicine? Source: Eur Respir J, 55 (1) 1901866; 10.1183/13993003.01866-2019 Year: 2020 What type of clinical evidence is needed to assess medical devices? Source: Eur Respir Rev 2016; 25: 259-265 Year: 2016 Laboratory investigations of infection in COPD: current best practice and future possibilities Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007 Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014 From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control Source: Annual Congress 2013 –The best of TB PANNET Year: 2013 The impact of hands-on respiratory management for physicians in clinical practice and its future perspective Source: Annual Congress 2012 - Improving education for the healthcare team and patients Year: 2012 Selecting patients in clinical practice Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation Year: 2012 Usefulness of the asthma predictive index in clinical practice: A systematic review and clinical epidemiological analysis Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012 CF clinical care and its delivery: current and future challenges Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission Year: 2019 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009